Source link : https://newshealth.biz/health-news/ema-recommends-romvimza-for-tenosynovial-giant-cell-tumor/
At its July 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization in the European Union for Romvimza (vimseltinib, Deciphera Pharmaceuticals) to treat adults with symptomatic tenosynovial giant cell tumor (TGCT) not amenable to improvement with surgery. TGCT is a rare, locally aggressive neoplastic proliferation […]
The post EMA Recommends Romvimza for Tenosynovial Giant Cell Tumor first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-28 16:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8